If you have been diagnosed with a melanoma of the eye that has spread to the liver, physicians at Jefferson developed a novel therapy to improve survival in uveal (ocular) melanoma patients with liver metastases.
What Does Immunoembolization Involve?
Immunoembolization involves injecting cytokines (drugs which stimulate or modulate immune responses) directly into the arteries supplying the liver, combined with embolization of the hepatic artery. The procedure improves the survival for patients with liver metastases from, at best, five months under conventional treatment to an average of 14.5 months. There are just a few other centers in the country that treat uveal (ocular) melanoma, and none through immunoembolization.
Why Choose Jefferson for Ocular Melanoma Treatment in Philadelphia?
If you or someone you love has been diagnosed with this disease, you can trust the care you receive at Jefferson as we have become a national referral center for patients whose ocular cancer has metastasized.